Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Cipla boosts investment in Ethris to advance mRNA therapies in emerging markets Cipla Limited has announced an additional investment of EUR 3 million in Ethris GmbH, further strengthening its involvement… byPallavi MadhirajuJune 18, 2024